Program
carboxymethylcellulose
Also written as “Carboxymethylcellulose and Glycerin based artificial tear”, “Optive” and “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”.
Its studies are mostly in Dry Eye Syndromes · Keratoconjunctivitis Sicca, led by 3 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AbbVie | 70 open or running | phase 4since Jul 10, 2009 | Oct 21, 2005 | none ahead |
| Innovative Medical | 20 open or running | phase 4since Nov 9, 2006 | Nov 9, 2006 | none ahead |
| Andover Research Eye Institute | 11 open or running | phase 4since Jun 24, 2026 | Jun 24, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Oct 21, 2005First study: phase 3 study in Dry Eye SyndromesNew to AbbVieAbbVie · NCT00243711 · 286 enrolled · United States
- Nov 9, 2006Innovative Medical's first study: phase 4 study in Dry Eye SyndromesNew to Innovative MedicalInnovative Medical · NCT00399230 · United States
- May 2, 2007Phase 4 study in Dry Eye SyndromesInnovative Medical · NCT00469157 · 92 enrolled · United States
- Aug 8, 2007No phase study in Dry Eye SyndromesAbbVie · NCT00514852 · 316 enrolled · United States
- Oct 12, 2007No phase study in Dry Eye SyndromesAbbVie · NCT00544713 · 228 enrolled · United States
- Jul 10, 2009Phase 4 study in Dry Eye SyndromesAbbVie · NCT00938704 · 71 enrolled · Germany
- Sep 29, 2009Phase 4 study in Dry Eye SyndromesAbbVie · NCT00987727 · 82 enrolled · France
- Jan 6, 2014Phase 4 study in Dry Eye SyndromesAbbVie · NCT02028754 · 180 enrolled · China
- Apr 16, 2014Phase 4 study in Dry Eye SyndromesAbbVie · NCT02117687 · 80 enrolled · France, United Kingdom
- Jun 24, 2026Andover Research Eye Institute's first study: phase 4 study in Dry Eye SyndromesNew to Andover Research Eye InstituteAndover Research Eye Institute · NCT07676084 · 60 planned · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 10 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07676084Dry Eye Syndromes · United States | 4 | Recruiting | Andover Research Eye Institute | Oct 2026 | 60 |
| NCT02117687Dry Eye Syndromes · France, United Kingdom | 4 | Completed | AbbVie | Jan 27, 2015 | 80 |
| NCT02028754Dry Eye Syndromes · China | 4 | Completed | AbbVie | May 2013 | 180 |
| NCT00987727Dry Eye Syndromes · France | 4 | Completed | AbbVie | Jul 2010 | 82 |
| NCT00938704Dry Eye Syndromes · Germany | 4 | Completed | AbbVie | Jun 2009 | 71 |
| NCT00544713Dry Eye Syndromes · United States | – | Completed | AbbVie | Jun 2008 | 228 |
| NCT00514852Dry Eye Syndromes · United States | – | Completed | AbbVie | Jan 2008 | 316 |
| NCT00469157Dry Eye Syndromes · United States | 4 | Completed | Innovative Medical | Apr 2008 | 92 |
| NCT00399230Dry Eye Syndromes · United States | 4 | Completed | Innovative Medical | ||
| NCT00243711Dry Eye Syndromes · United States | 3 | Completed | AbbVie | Apr 2006 | 286 |
How it is read
Names in the registry
- “Carboxymethylcellulose and Glycerin based artificial tear”, 2 entries
- “Optive”, 2 entries
- “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”, 1 entry
- “carboxymethylcellulose 0.5%/glycerin 0.9%”, 1 entry
- “Sodium Carboxymethylcellulose”, 1 entry
Conditions, from the studies’ own filings
- Dry Eye Syndromes, 8 studies
- Keratoconjunctivitis Sicca, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.